Neuraxis, Inc. (NRXS) Dividend History

Neuraxis, Inc. (NRXS) is a biotechnology company focused on developing neurotherapeutic products targeting neurological and psychiatric disorders. The company specializes in creating innovative treatments leveraging its expertise in neurostimulation and neurotechnology to address unmet medical needs in neurological conditions.

11611 N. Meridian St, Carmel, IN, 46032
Phone: (812) 689-0791
Website: http://www.neuraxis.com

Dividend History

Neuraxis, Inc. currently does not pay dividends

Company News

  • NeurAxis, Inc. will report its Q1 2025 financial results on May 12, 2025, before market open, and host a conference call on the same day at 9:00 am ET to review the results.

    GlobeNewswire Inc.
  • Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock. Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 52.6% to $0.1295 after the company agreed to divest AVTX-800 series. Shengfeng Development Limited (NASDAQ: SFWL) rose 45.3% to $13.53. Cognyte Software Ltd. (NASDAQ: CGNT) gained 24.8% to $5.77 after the company reported better-than-expected second-quarter financial results and issued FY24 guidance above estimates Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 24% to $0.4210. Xos, Inc. (NASDAQ: XOS) gained 23% to $0.3836. Xos was awarded contract by State of California to provide electric step vans to state and local agencies. The Beauty Health Company (NASDAQ: SKIN) jumped 16.6% to $6.38 after the company announced business transformation program to drive profitability and growth. The company’s board authorized a $100 million share repurchase. Bit Digital, Inc. (NASDAQ: BTBT) rose 15.7% to $2.4080. Bitfarms Ltd. (NASDAQ: BITF) gained 15.5% to $1.2699. MoonLake Immunotherapeutics (NASDAQ: MLTX) rose 15.2% to $60.60 after rival Acelyrin reported Part B of its Phase 2b/3 trial of izokibep for Hidradenitis Suppurativa failed to meet its primary endpoint. MoonLake is also working on a treatment for Hidradenitis Suppurativa. TeraWulf Inc. (NASDAQ: WULF) rose 14% to $1.9499. Stronghold Digital Mining, Inc. (NASDAQ: SDIG) gained 13.2% to $4.71. NextNav Inc. (NASDAQ: NN) gained 12.6% to $5.05. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares jumped 12.1% to $0.4104 after jumping more than 36% on Monday. ImmunityBio, Inc. (NASDAQ: IBRX) gained 11% to $1.7100. ImmunityBio announced $470 million in equity and debt financing from founder Dr. Patrick Soon-Shiong and Nant entities. Ascent Solar Technologies, Inc. (NASDAQ: ...

    Benzinga
Page data last updated 08/19/2025 16:57:24 UTC